ArticleInternational immunopharmacology2023

The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma.

Andrea Frejlachova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.